Polymyxin b/tigecycline combination vs. polymyxin b or tigecycline alone for the treatment of hospital-acquired pneumonia caused by carbapenem-resistant enterobacteriaceae or carbapenem-resistant acinetobacter baumannii

HIGHLIGHTS

• who: Kang Chang1u2020 and collaborators from the University of Su00e3o Paulo, Brazil have published the research: Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii, in the Journal: (JOURNAL) of 08/09/2021
• what: The authors aimed to evaluate the efficacy and safety of appropriate PMB/TGC combination therapy in treating HAP caused by CRO when compared with appropriate PMB or TGC alone. The authors concluded that patients in the PMB/TGC combination group did not show . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.